Docosa<wbr/>tetraenoyl Ethanolamide

Docosatetraenoyl Ethanolamide

CAT N°: 90385
Price:

From 102.00 86.70

Docosatetraenoyl ethanolamide (DEA) is an endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA. DEA acts on CB1 receptors with potency and efficacy similar to that of AEA.{2713} However, its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated.{1172}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-(2-hydroxyethyl)-7Z,10Z,13Z,16Z-docosatetraenamide
  • Correlated keywords
    • endocannabinoids neurotransmitters ethanolamides docosatetraenoic acid fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic
  • Product Overview:
    Docosatetraenoyl ethanolamide (DEA) is an endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA. DEA acts on CB1 receptors with potency and efficacy similar to that of AEA.{2713} However, its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated.{1172}

We also advise you